Insider · CIK 0001260426
William J Federici
Files at ZYNE (Zynerba Pharmaceuticals, Inc.), STVN (Stevanato Group S.p.A.). First filing Jun 26, 2026, latest Jun 26, 2026.
In brief
William J Federici files SEC Form 4 as director at STVN (Stevanato Group S.p.A.), and also at ZYNE (Zynerba Pharmaceuticals, Inc.). Since Jun 26, 2026, William J Federici has reported 0 open-market buys worth $0 and 1 open-market sell worth $26k, the latest filed on Jun 26, 2026.
A track record needs three past buys with six months of prices behind them; William J Federici has 0, so none is measured yet.
The newest scored trade: sold $26k of STVN on Jun 15, 2026, filed Jun 26, 2026, scored 35 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $26k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
STVN: Stevanato Group S.p.A.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Stevanato Group S.p.A. | $26k 1,493 shares | -5% | +24% from low-40% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | STVN Stevanato Group S.p.A. | AGrant or award Ordinary Shares | +4,975 | $0.00 | $0 | 28,484 | Jun 26, 2026 |
| Jun 15, 2026 | STVN Stevanato Group S.p.A. | SOpen-market sale Ordinary Shares | -1,493 | $17.09 | $26k | 26,991 | Jun 26, 2026 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | UTender of shares Common Stock | -27,954 | - | - | 47,824 | Oct 11, 2023 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | UTender of shares Common Stock | -47,824 | - | - | 0 | Oct 11, 2023 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -34,663 | - | - | 0 | Oct 11, 2023 |
| Oct 10, 2023 | ZYNE Zynerba Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -71,736 | - | - | 0 | Oct 11, 2023 |
Questions about William J Federici
Answered from the filings on this page, as of the latest one.
Is William J Federici buying or selling?
In the last 12 months William J Federici reported 0 open-market buys worth $0 and 1 open-market sell worth $26k on SEC Form 4; the latest was sold $26k of STVN on Jun 15, 2026. Grants, option exercises and tax withholding are not counted.
How did William J Federici's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William J Federici has 0.
Where does William J Federici file Form 4?
William J Federici has filed Form 4 at STVN (Stevanato Group S.p.A.); ZYNE (Zynerba Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.